World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Diagnostics companies and testing labs at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
27 diagnostics companies and testing labs are at World CDx 2026 — 24 presentations on the program. Most represented: Agilent (3 on the program), Abbott (3 on the program), Caris Life Sciences (2 on the program). 27 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–18 of 27 organizations
| Organization | World CDx 2026 Attendance |
|---|---|
Agilent Santa Clara, CA | ◇Expertise Partner |
Life science and diagnostics company whose companion diagnostics group co-develops assays with pharma partners; co-developed HercepTest, an early companion diagnostic, in 1998. | Panel Tue Oct 6 12:30pm Companion Diagnostics from Biomarker Discovery to Global Launch: Building Better Partnerships Across Science, Regulation, & Commercialization Clinical & companion diagnostic developmentDrug–diagnostic commercialization & access Panel Wed Oct 7 3:10pm Innovating Global Rx-Dx Trial Pathways Through Strategic & Compliant Co-Development Partnerships to Deliver Harmonized Precision Medicine Solutions Clinical & companion diagnostic developmentDrug–diagnostic commercialization & access |
Abbott Abbott Park, IL | ◇Program Partner |
Healthcare company with a broad in vitro diagnostics portfolio; its molecular diagnostics unit makes oncology FISH and PCR assays and develops companion diagnostics. | Talk Wed Oct 7 2:10pm From Assay to Asset: How End‑to‑End Companion Diagnostic Partnerships Deliver Strategic Platform Selection, Clinical Development Alignment, & Reliable Execution Clinical & companion diagnostic development |
Caris Life Sciences Irving, TX | ◇Expertise Partner |
Molecular profiling company using whole-exome and whole-transcriptome sequencing plus AI on a large clinico-genomic database for therapy selection and drug development. | Panel Tue Oct 6 5:10pm The Role of AI in the Future of Companion Diagnostics Multimodal & AI-enabled precision medicineClinical & companion diagnostic development Panel Wed Oct 7 11:20am Beyond the Slide: Tissue AI as the Anchor for Multimodal Biomarker Discovery & Global Deployment Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Foundation Medicine Boston, MA | ◇Expertise Partner |
Comprehensive genomic profiling company offering tissue and blood cancer tests and developing companion diagnostics with drug developers. | Talk Tue Oct 6 11:30am A Dual Tissue & Liquid Biopsy Strategy: The TEPMETKO® Companion Diagnostic Journey Clinical & companion diagnostic developmentLiquid biopsy & MRD Panel Tue Oct 6 2:00pm Single-Cell Becomes a Reality: The Next Generation of Therapy Selection Biomarkers Biomarker discovery & translation |
Natera Austin, TX | ◇Expertise Partner |
Cell-free DNA testing company whose Signatera test tracks molecular residual disease, with a real-world data platform for drug developers. | Talk Tue Oct 6 8:35am What Becomes Possible Combing MRD, Multi-Omics & RWD Insights Liquid biopsy & MRDMultimodal & AI-enabled precision medicine Talk Thu Oct 8 11:00am Accelerate Early Phase Drug Development with MIIRA, Natera’s Longitudinal ctDNA & Multi-Modal Real-World Data Platform Liquid biopsy & MRDMultimodal & AI-enabled precision medicine |
Almac Craigavon, UK | ◇Program Partner |
Diagnostics arm of the Almac Group offering pharma genomic services, clinical trial assays and companion diagnostic development from labs in Europe and the US. | Talk Wed Oct 7 11:20am Partnering for Success: Leveraging Diagnostic Regulatory & Quality Systems Expertise to Achieve Compliance in EU (IVDR) & UK Clinical Trials Clinical & companion diagnostic development |
Biodesix Louisville, CO | ◇Program Partner |
Lung disease diagnostics company with Medicare-covered blood tests that also offers biopharma partners its testing technology and laboratory services. | Talk Wed Oct 7 11:20am Building a Fit-for-Purpose TPD Biomarker: Kinesin Quantification in PBMCs from Discovery Through Clinical Development Biomarker discovery & translation |
Biovica Uppsala, Sweden | ◇Program Partner |
Makes DiviTum TKa, an FDA-cleared blood test measuring thymidine kinase activity to track tumor proliferation, and runs it for oncology drug trials. | Talk Thu Oct 8 11:50am Beyond Maximum Tolerated Dose: Using a Dynamic Pharmacodynamic Biomarker, TKa, for Oncology Drug Development Biomarker discovery & translation |
Burning Rock Dx Guangzhou, China | ◇Program Partner |
Chinese provider of next-generation sequencing cancer tests that partners with drug developers on companion diagnostics for global trials. | Talk Wed Oct 7 12:10pm Regional Pathways, Global Evidence: Advancing NGS-Based CDx Development Clinical & companion diagnostic development |
ClearNote Health San Diego, CA | ◇Expertise Partner |
Cancer detection company whose Virtuoso platform sequences plasma cell-free DNA for 5hmC epigenetic marks, used in blood tests and drug development research. | Talk Wed Oct 7 8:30am Cancer Biology Through 5hmC Liquid Biopsy: From Early Detection to Drug Development Liquid biopsy & MRDBiomarker discovery & translation |
EntroGen Woodland Hills, CA | ◇Spotlight Partner |
Makes molecular test kits for oncology and hematology, including an FDA-approved PCR companion diagnostic for RAS mutations in colorectal cancer. | Talk Wed Oct 7 12:40pm Roadmap for Global Clinical Trial Assays: Leveraging Distributed Kits for CDx Success Clinical & companion diagnostic development |
GRAIL Menlo Park, CA | ◇Expertise Partner |
Develops methylation-based blood tests for multi-cancer early detection, using sequencing and machine learning, and works with drug developers on trials. | Talk Tue Oct 6 2:50pm Beyond Detection: The Role of Multi-Cancer Early Detection (MCED) in Advancing Oncology Trial Execution Liquid biopsy & MRD |
Guardant Health Palo Alto, CA | ◇Expertise Partner |
Liquid biopsy company whose ctDNA sequencing tests, including Guardant360, guide therapy selection and support trial screening and companion diagnostics. | Talk Tue Oct 6 9:25am Breaking Barriers in Precision Oncology: One Global Companion Diagnostic Platform Across Liquid & Tissue Clinical & companion diagnostic developmentLiquid biopsy & MRD |
Myriad Genetics Salt Lake City, UT | ◇Expertise Partner |
Genetic testing company offering hereditary cancer, tumor and MRD tests, plus companion diagnostic development and trial testing for biopharma. | Talk Tue Oct 6 4:40pm Clinical Validation of Myriad Genetics’ Ultra-Sensitive Pan-Cancer WGS-Based Precise MRD Assay Liquid biopsy & MRDClinical & companion diagnostic development |
One Biosciences Paris, France | ◇Expertise Partner |
Institut Curie spinout combining single-cell profiling of tumor samples with AI to find predictive biomarkers and support therapy selection and trial design. | Panel Tue Oct 6 2:00pm Single-Cell Becomes a Reality: The Next Generation of Therapy Selection Biomarkers Biomarker discovery & translation |
Predicine Hayward, CA | ◇Spotlight Partner |
Liquid biopsy company with cell-free DNA and RNA assays for treatment selection, residual disease monitoring and companion diagnostic development, run centrally or as kits. | Talk Wed Oct 7 12:40pm Session Reserved for Predicine Liquid biopsy & MRDClinical & companion diagnostic development |
Quest Diagnostics Secaucus, NJ | ◇Expertise Partner |
US clinical laboratory company running a national testing network, including esoteric and anatomic pathology labs, with insights drawn from its large lab-results database. | Talk Tue Oct 6 12:00pm Multiple Diagnostic Pathways to Expand Patient Reach Clinical & companion diagnostic developmentDrug–diagnostic commercialization & access |
Roche Basel, Switzerland | ◇Expertise Partner |
Basel-based pharmaceutical and diagnostics group; its diagnostics division supplies in vitro tests across molecular, tissue, immunoassay, sequencing and point-of-care testing. | Talk Tue Oct 6 10:40am More Than a Diagnosis: A Patient’s Perspective on the Power of Precision Medicine Drug–diagnostic commercialization & access |
Instantly find 20 buyers from diagnostics companies and testing labs
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World CDx 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction